This inventor holds 3 USPTO granted patents. Top assignees: Merck Frosst Canada, Inc., Merck Frosst Canada & Co.. Active years: 1996-2007.
Company Filing History:
Years Active: 1996-2007
Title: Wanda A. Cromlish: Innovator in Biochemical Research
Introduction
Wanda A. Cromlish is a distinguished inventor based in Montreal, Canada. She has made significant contributions to the field of biochemical research, particularly in the study of cyclooxygenases and protein tyrosine phosphatases. With a total of 3 patents to her name, her work has had a profound impact on medical research and therapeutic development.
Latest Patents
Cromlish's latest patents include groundbreaking inventions such as the "Human cyclooxygenase-2 cDNA and assays for evaluating cyclooxygenase-2 activity." This invention discloses a human cyclooxygenase-2 cDNA, a human cyclooxygenase-2, and assays for preferentially and independently measuring cyclooxygenase-2 or cyclooxygenase-1 activity present in a given sample. Another notable patent is the "Intact cell assay for protein tyrosine phosphatases using recombinant baculoviruses," which showcases her innovative approach to biochemical assays.
Career Highlights
Throughout her career, Cromlish has worked with prominent companies in the pharmaceutical industry, including Merck Frosst Canada, Inc. and Merck Frosst Canada & Co. Her experience in these organizations has allowed her to develop and refine her inventions, contributing to advancements in medical science.
Collaborations
Cromlish has collaborated with esteemed colleagues such as Brian P. Kennedy and Gary P. O'Neill. These partnerships have fostered a collaborative environment that has enhanced her research and innovation efforts.
Conclusion
Wanda A. Cromlish is a remarkable inventor whose work in biochemical research has led to significant advancements in the understanding of cyclooxygenases and protein tyrosine phosphatases. Her contributions continue to influence the field and inspire future innovations.